Ngai Cheung Lau

Hong Kong Life Sciences & Technologies Group Ltd. is an investment holding company. It operates through the following business segments: Anti-aging and Stem Cell Technology Business; Trading Business; Money Lending Business; and Securities Investment Business. The Anti-aging and Stem Cell Technology Business segment engages in the provision of anti-aging services; distribution of biomedical and life science products; health check and beauty service; and leasing of anti-aging service platform. The Trading Business segment engages in trading of electronic components and healthcare products. The Money Lending Business segment offers loan financing. The Securities Investment Business segment engages in trading and investment of securities. The company was founded on October 30, 2000 and is headquartered in Hong Kong.

Common Sense Ltd. develops non-intrusive diagnostic panty-liners and swabs, containing built-in sensing capabilities. Its products accurately monitor suspected amniotic leak and vaginal health. The firm's technology also resulted in the development of indicators that are more sensitive to the presence of amniotic fluid in vaginal secretions than to urine. Common Sense was founded by Amnon Kritzman in 1999 and is headquartered in Caesarea, Israel.